Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.

MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

A new method enables optical devices that more closely match their design specifications, boosting accuracy and efficiency.

Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.

Using fluorescent labels that switch on and off, MIT engineers can study how molecules in a cell interact to control the cell’s behavior.

By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.

Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.